Edgestream Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-987
Closed -$228K 939
2023
Q4
$228K Sell
987
-580
-37% -$134K 0.02% 766
2023
Q3
$229K Sell
1,567
-1,003
-39% -$146K 0.02% 769
2023
Q2
$594K Buy
+2,570
New +$594K 0.05% 492